MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma

Acta Haematol. 2009;122(1):42-5. doi: 10.1159/000235820. Epub 2009 Aug 29.
No abstract available

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics*
  • Adult
  • Aged
  • Aged, 80 and over
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / genetics*
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Pyrazines / therapeutic use

Substances

  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Boronic Acids
  • Pyrazines
  • Bortezomib